-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, ISC5iNEC1yECjp+AF9Kc0EeNxZlv9aoO4x26g53EMRg3HvdtqNjOaKW+l36/K2gD 1IdIzDIn631eVK40Ddq+aA== 0000893220-08-001798.txt : 20080613 0000893220-08-001798.hdr.sgml : 20080613 20080613135030 ACCESSION NUMBER: 0000893220-08-001798 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080610 ITEM INFORMATION: Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers FILED AS OF DATE: 20080613 DATE AS OF CHANGE: 20080613 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MEDQUIST INC CENTRAL INDEX KEY: 0000884497 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374] IRS NUMBER: 222531298 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-19941 FILM NUMBER: 08897886 BUSINESS ADDRESS: STREET 1: 1000 BISHOPS GATE BLVD STREET 2: SUITE 300 CITY: MOUNT LAUREL STATE: NJ ZIP: 08054-4632 BUSINESS PHONE: 8568108000 MAIL ADDRESS: STREET 1: 1000 BISHOPS GATE BLVD STREET 2: SUITE 300 CITY: MOUNT LAUREL STATE: NJ ZIP: 08054-4632 8-K 1 w60694e8vk.htm FORM 8-K e8vk
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 10, 2008
MedQuist Inc.
(Exact name of registrant as specified in its charter)
         
New Jersey   0-19941   22-2531298
 
(State or other jurisdiction
of incorporation) 		  (Commission
File Number) 		  (I.R.S. Employer
Identification No.)
     
1000 Bishops Gate Blvd., Suite 300, Mt. Laurel, NJ   08054
 
(address of principal executive offices)   (Zip Code)
Registrant’s telephone number, including area code:   (856) 206-4000
 
 
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 

 

Item 5.02.   Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
     Howard Hoffmann’s service as the interim President and Chief Executive Officer of MedQuist Inc., (the “Company”), and the related engagement of Nightingale & Associates, LLC (“Nightingale”), terminated consensually on June 10, 2008. Mr. Hoffmann is the sole managing partner of Nightingale.
     On June 10, 2008, the board of directors of the Company appointed the Company’s current Chief Technology Officer, Mark Ivie, to the additional positions of interim President and Chief Executive Officer effective as of June 11, 2008. Mr. Ivie’s base salary will be increased by 20% to $285,516 effective as of June 11, 2008. Except as set forth above, Mr. Ivie’s compensation and benefits will remain the same as described in the Company’s Form 10-K/A filed with the Securities and Exchange Commission on April 29, 2008 (the “Form 10-K/A”).
     Information required by Items 104(b), (d), (e) and Item 404(a) for Mr. Ivie has been included in the Form 10-K/A and such information is incorporated herein by reference.

 

 

SIGNATURE
     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
         
  MEDQUIST INC.
 		  
Date: June 13, 2008  By:   /s/ Mark Sullivan    
    Mark Sullivan   
    General Counsel, Chief Compliance Officer
and Secretary 		  
 

 

-----END PRIVACY-ENHANCED MESSAGE-----